Skip to main content
Signal8

WINDWARD BIO GROUP AG (WWB)

Operates as a holding company whose subsidiaries develops and commercializes therapeutics

Sector: Biological Products, (No Diagnostic Substances)

Industry: Medical - Pharmaceuticals

Windward Bio Group AG logo

Windward Bio Group AG

NASDAQ:WWBHealthcare
+5.40%$30.04
CLOSED
AH$30.04+0.00%vs close
Mkt Cap$1.74B
EV-
Float10.29M
O/S58.04M
VOL238K sh
$ Vol$6.29M
RVOL0.31×
Inst Own-
Net Cash/Sh-
Dilution
Windward Bio Group AG logoNASDAQ:WWBClosed$30.04+5.40%
Pipeline2 lead-sponsored trials·2 active0 completed

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
  • Phase 2
    Recruiting

    Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

    WIN378, Placebo

    Asthma

    Enrollment
    600
    Start
    Jul 2025
    Primary Completion
    Oct 2028est.
    Completion
    Nov 2028est.
    NCT07120503
  • Phase 2
    Recruiting

    A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

    WIN378, Placebo

    COPD (Chronic Obstructive Pulmonary Disease)

    Enrollment
    105
    Start
    Jun 2026
    Primary Completion
    Dec 2027est.
    Completion
    Jan 2028est.
    NCT07646587